Health
Inhaled steroids reduce SARS-CoV-2-related genes in COPD – News-Medical.Net
A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.
The chronic lung condition called COPD (chronic obstructive pulmonary disease) increases the risk of severe COVID-19.
Inhaled corticosteroids (ICS) are commonly prescribed to stabilize respiratory function in these patients, but the associated risk of bacterial infection has daunted some healthcare professionals from using them. Moreover, in vitro, studies show that they have an immunosuppressive effect on cells exposed to viruses. There is no evidence to reveal the effects of ICS on either sus…
-
General10 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General12 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General13 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business10 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher